1.Evaluation on Standard of TCM Literature Metadata
Ling ZHU ; Tong YU ; Zhulyu ZHANG ; Meng CUI
World Science and Technology-Modernization of Traditional Chinese Medicine 2015;17(4):763-767
All elements and refinements had been built in ontology with protégé 4.1, which can be used to record over 20 classic Chinese medicine books in related author, publisher, storage site, edition, form and arrangement of lines in calligraphy, and etc. It also realized the graphical display based on ontology. It gave brief analysis on elements which had been used or without using. Studies showed that Web Ontology Language (OWL) can express all elements of TCM literatures clearly. This study indicated that element refinements should be considered to add in the amendment of ISO International Standards application for further improvement.
2.Research of TCM clinical terms and the suggestions for system improvement
Yan DONG ; Ling ZHU ; Tong YU ; Meng CUI ; Haiyan LI
International Journal of Traditional Chinese Medicine 2014;(11):965-968
This study analyzed the current clinical terminology standardization, systematization research status of traditional Chinese medicine(TCM). The previous version of the TCM clinical term system had some problems including imperfect classification structure, unclear relationship between concepts and so on, which made the TCM clinical terminology system(TCMCTS) difficult to support the clinical practice of TCM. The suggestions for system improvement were using ontology method to build TCMCTS concept model bases on the previous researches and data extracted from TCM clinical electronic medical record, and top-level-ontology accordance with ISO standards. The study also tried to summarize the ‘semantic network between classes’ through semantic relationships.
3.Co-appearance analysis of papers on medical informatics
Fengqing QI ; Meng ZHANG ; Panpan HU ; Yu ZHANG ; Qian ZHU
Chinese Journal of Medical Library and Information Science 2015;(2):34-37
The current situation of medical information was analyzed by displaying the co-appearance of countries and time, top 5 journals and co-appearance of subject headings in papers on medical information published in 1995-2014 with the papers on medical informatics covered in ISI Web of Science Database as an sample , in order to promote the study and provide reference for the related persons and institutions .
4.Executive function and working memory of patients with mild cognitive impairment
Cuiping GUO ; Chunhua XI ; Youling ZHU ; Yu MENG ; Kai WANG
Chinese Journal of Neurology 2009;42(4):237-240
Objective To investigate the characteristics of the executive function and working memory in patients with mild cognitive impairment (MCI), and the relations between working memory and executive function and the effects of working memory on patient' s daily functioning.Methods Thirty patients with MCI and 30 healthy elderly subjects were tested with a wide neuropsychoingical battery of tests including those of executive function, working memory and other cognition domain tests.Executive function was evaluated by using the verbal fluency test (VFT), color trail test (CTT), digital span (DS).Results The results showed the presence of significant executive function and working memory impairment in MCI patients as compared with the healthy controls.The scores of executive function test in MCI patients were decreased significantly in CTT (130.8±58.2 vs 52.0±13.5), CTT-B (210.2±81.8 vs 121.0±33.4),DS (3.4±0.9 vs 4.2±1.1), VFT (8.9±5.4 vs 16.4±5.4) and visuo-objective working memory (0.73±0.12 vs 0.85±9.18) respectively (t = 7.108, 5.159,-2.544,-4.879, and-4.351, all P <0.01 or P < 0.05) .In the stepwise liner regression analysis objective working memory test made a significant independent contribution to ADL (β =-0.720, t =-3.571, P < 0.01).Conclusion The patients with MCI have the deficit in executive function and working memory.Visuo-objective working memory is closely correlated with general cognitive function such as daily function, resulting in daily function decline.
5.Current status and prospectives of proton and heavier-ion beam therapy for tumor in the digestive system.
Jin-ming YU ; Wan-qi ZHU ; Xue MENG
Chinese Journal of Gastrointestinal Surgery 2011;14(11):827-829
Particle radiotherapy using proton and heavier-ion beam was first proposed for clinical application by Robert Wilson in 1946. Compared to conventional photon radiation, proton and heavier-ion beam has significant physical advantage, and heavier-ion has unique biological characteristics. With the development of accelerator and radiation technique, it is being investigated for tumor treatment in many clinical centers. This article reviews the current status of clinical application of particle therapy using proton and heavier-ion beam in digestive system tumor.
Animals
;
Digestive System Neoplasms
;
therapy
;
Heavy Ion Radiotherapy
;
Heavy Ions
;
therapeutic use
;
Humans
;
Protons
;
therapeutic use
6.Case formulation report of cognitive behavior therapy for adjustment disorder: A case study
Qian XU ; Jianping WANG ; Meng YU ; Yawen ZHU
Chinese Mental Health Journal 2017;31(1):64-71
This study discussed how to make a cognitive behavioral therapy-orientated case formulation for the client who was diagnosed as adjustment disorder,and also the importance of the role of case formulation in guiding the whole counseling process.Four months before the client asked for psychological help,he gradually showed symptoms of depression,insomnia,work inefficiency and being suspicious of self-capacity because of the promotion and the change of supportive system.We did the psychological counseling aiming at his cognitive,emotional and behavioral problems.In addition,the Beck Depression Inventory (BDI),Beck Anxiety Inventory (BAI) and Subjective Units of Distress Scale (SUDs) were used to evaluate his emotional condition before,after and during the counseling.Results demonstrated that the client's emotional,cognitive and social functions were significantly improved,achieving the expected goals.In conclusion,the cognitive behavioral therapy-orientated case formulation for adjustment disorder could effectively guide the counseling practice.
7.Body composition measurement methods and their clinical application
Meng YANG ; Changzhen ZHU ; Jianchun YU ; Weiming KANG
Chinese Journal of Clinical Nutrition 2015;23(2):125-130
Body composition measurement could significantly facilitate evaluating the content of various body components,getting information about the health status and assessing the diagnosis,treatment,test,and prognosis of several diseases.Human health will be seriously affected by the imbalance of body composition.Body composition measurement methods are generally divided into local measurement methods and general measurement methods.The former ones include skinfold thickness measurement,ultrasonic measurement,computed tomography and nuclear magnetic resonance measurement;while the latter ones include anthropometry,underwater weighing measurement,air displacement measurement,biological resistance measurement,near infrared absorption measurement,dual-energy X-ray absorptiometry measurement,isotope dilution measurement,potassium isotope measurement and three-dimensional body scanning measurement,etc.This article reviews a variety of body composition measurement methods and their clinical application.
8.Quantitative evaluation of the thrombosis elasticity in vivo by shear wave elastography
Yu YUAN ; Ying ZHU ; Jinmei GAO ; Meng LIU ; Weifang YIN
Chinese Journal of Ultrasonography 2015;(7):615-617
Objective To evaluate the diagnostic value of shear wave elastography on deep venous thrombosis in different stage.Methods Models of rabbits'deep venous thrombosis have been established to noninvasively measure Young's moduli of thrombosis in day 1 ,4,7,10 and 14 respectively by shear wave elastography.Results The elastic modulus of thrombosis increased with increment of the stages of thrombosis.Specifically,the mean Young's moduli of thrombosis increased from (4.0±1 .42)kPa (day 1)to (25.71 ±6.09)kPa (day 14),with statistical differences between each two observation time points (P <0.05).Conclusions Shear wave elastography can effectively reflect the elasticity of thrombosis in different stages,and the stage of thrombosis can be estimated judging by quantitative ultrasound elasticity preliminarily.
9.ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma.
Yu-Qiao DIAO ; Fan QU ; Ming-Juan YANG ; Jian-Hui MENG ; Xiu-Li ZHU ; Jian CHEN
Chinese Journal of Contemporary Pediatrics 2014;16(6):619-623
OBJECTIVETo investigate the methylation status of zonula occludens-1 (ZO-1) gene promoter and its clinical significance in children with stage IV non-Hodgkin lymphoma (NHL) and to provide a basis for further etiological study and early diagnosis of this disease.
METHODSFifty-five children with a confirmed diagnosis of stage IV NHL (40 cases of T-NHL and 15 cases of B-NHL) were selected as the case group, and 20 children with diseases other than hematologic malignancies were selected as the control group. Bone marrow samples were collected from these subjects. Methylation-specific PCR (MS-PCR) was applied to evaluate the methylation status of ZO-1 gene promoter, and the integrated optical density (IOD) was determined. RT-PCR was used to measure the mRNA expression of ZO-1.
RESULTSMS-PCR showed that the methylated bands of ZO-1 gene promoter were found in 39 (70.9%) of 55 patients in the case group before treatment, while no ZO-1 gene promoter methylation was detected in the control group. With close tracking of 47 cases in the study group, consisting of 32 cases of T-NHL and 15 cases of B-NHL, the rates of ZO-1 gene promoter methylation prior to treatment were 72% and 67%, respectively, (P>0.572). The cases of T-NHL and B-NHL showed no significant changes in methylation rate in the early and middle phases of chemotherapy (P>0.05), but they showed significant changes in methylation rate in the late phase of chemotherapy (P<0.05). RT-PCR showed that the NHL cases carrying methylated ZO-1 gene had no mRNA expression of ZO-1, while all children in the control group had mRNA expression of ZO-1. There was no linear relationship between the total number of peripheral blood leukocytes and ZO-1 gene IOD (r=0.093, P=0.575); a positive correlation was found between the number of malignant cells in bone marrow and ZO-1 gene IOD (r=0.669, P<0.001).
CONCLUSIONSZO-1 gene shows a hypermethylation status in children with NHL, and the methylation level is positively correlated with the number of malignant cells in bone marrow. ZO-1 may be used as a novel molecular marker in early diagnosis, outcome assessment, prognostic evaluation, and detection of minimal residual disease.
Adolescent ; Child ; Child, Preschool ; DNA Methylation ; Female ; Humans ; Infant ; Lymphoma, Non-Hodgkin ; genetics ; Male ; Promoter Regions, Genetic ; Zonula Occludens-1 Protein ; genetics
10.Stable interference on P210(bcr/abl) gene expression by lentiviral vector-delivered shRNA in vitro and in vivo.
Yu-Feng ZHU ; Yuan-Zhan WANG ; Fan-Yi MENG
Journal of Experimental Hematology 2012;20(5):1090-1094
P210(bcr/abl) fusion gene is indispensable for generation and progression of chronic myeloid leukemia (CML). Small molecule inhibitors, such as imatinib, are effective for P210(bcr/abl) gene mediated CML, but drug resistance may occur. The unique fusion junction of P210(bcr/abl) gene is an attractive target for therapeutic intervention using RNA interference (RNAi). This study was purposed to constructed the BaF3 cell line by viral vector which can stably express P210(bcr/abl) shRNA and P210(bcr/abl) mRNA at the same time, and investigate the effect of lentiviral-victor-delivered shRNA on P210(bcr/abl) gene expression. The infective rate of lentiviral vector on BaF3 cells with P210(bcr/abl) gene was assayed by fluorescent microscopy; the cell proliferation ability was determined by trypan blue exclusion; the P210(bcr/abl) mRNA and protein expressions were detected by RT-PCR and Western blot respectively. The results found that stable expression of the P210(bcr/abl) shRNA resulted in obvious inhibition of P210(bcr/abl) mRNA and protein expression and increased sensitivity of these P210(bcr/abl) gene transformed Ba/F3 cells to imatinib. The IC(50) to imatinib in these cells decreased < 50% as compared with Ba/F3-P210(bcr/abl) cells which did not express P210(bcr/abl) mRNA. The survival time of the lethal dose irradiated mice induced by intravenous injection of these Ba/F3 cells was longer than the other group induced by Ba/F3-P210(bcr/abl). It is concluded that stable expression of shRNA targeting the P210(bcr/abl) gene fusion junction may potentiate the effects of conventional therapy for CML.
Animals
;
Fusion Proteins, bcr-abl
;
genetics
;
metabolism
;
Gene Expression
;
Genetic Vectors
;
Lentivirus
;
genetics
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
genetics
;
metabolism
;
Mice
;
NIH 3T3 Cells
;
RNA, Small Interfering
;
genetics